Fundz

MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D. and Appointment of David M. Urso as Successor

PUBLIC · LITSJun 02, 2023

Company

Lite Strategy, Inc.

San DiegoBiotechnologyFinancial ServicesHealth CarePharmaceuticalConsulting

Description

MEI Pharma, Inc. , a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that, in connection with the Company’s previously announced succession plan, Daniel P. Gold, Ph.D’s tenure as the president and chief executive officer of MEI will end on June 2, 2023 and the Company’s board of directors has appointed David M

Quick answer

MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D. and Appointment of David M. Urso as Successor (June 2, 2023). Lite Strategy, Inc. is based in San Diego, California, United States.

What did Lite Strategy, Inc. announce on June 2, 2023?
MEI Pharma, Inc. , a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that, in connection with the Company’s previously announced succession plan, Daniel P. Gold, Ph.D’s tenure as the president and chief executive officer of MEI will end on June 2, 2023 and the Company’s board of directors has appointed David M
What does Lite Strategy, Inc. do?
MEI Pharma, Inc. (Nasdaq: MEIP) is a pharmaceutical company focused on developing potential new therapies for cancer.
Where is Lite Strategy, Inc. based?
Lite Strategy, Inc. is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
LumaBridge (May 31, 2023), Piramal Critical Care (June 6, 2023), Nephron Pharmaceuticals (June 8, 2023) and Damona Pharmaceuticals (June 13, 2023) also announced leadership changes within 45 days of Lite Strategy, Inc.

Source: Fundz verified event record.

Other recent leadership changes in Financial Services and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Lite Strategy, Inc., and when

A new leader at Lite Strategy, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Lite Strategy, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lite Strategy, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lite Strategy, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lite Strategy, Inc.

Location

3611 Valley Centre Drive

San Diego, California, United States

About

MEI Pharma, Inc. (Nasdaq: MEIP) is a pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma’s portfolio of drug candidates includes clinical stage candidates with differentiated mechanisms of action intended to address unmet medical needs and deliver improved benefit to patients, either as standalone treatments or in combination with other therapeutic options. For more information, please visit www.meipharma.com. Follow us on Twitter @MEI_Pharma and on LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lite Strategy, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Justin
Likely contact at this company
••••••••@••••••••

See Justin's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Lite Strategy, Inc.'s next move

Learn about Strategic plan

Lite Strategy, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.